Raisa Lowe

Vice President, Head of CMC  • Arbor Biotechnologies

Raisa Lowe, MS, has significant experience in cell and gene therapy, monoclonal antibodies, protein therapeutics, vaccines, and small molecule therapeutics from her 30-year career in the Biopharmaceutical industry. Raisa joined Arbor Biotechnologies as VP, Head of CMC in 2022. Prior to Arbor, Ms. Lowe worked at Editas Medicine, Juno Therapeutics, Argos Therapeutics, and Novartis in a variety of roles including CMC, Quality and Regulatory. Ms. Lowe received her MS in Biotechnology from Johns Hopkins University

Also Speaking

Amritha Jaishankar

Executive Director, Cell and Gene Therapy Center • IQVIA

Nicole Paulk

Professor • University of California San Francisco

Ana Rosa Sáez Ibáñez

Research Analyst, Clinical Accelerator and Venture Fund • Cancer Research Institute

Also Speaking


Post-Event Report

Download the post-event report for Advanced Therapies Week 2024.

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.